Newly Discovered Enzyme SelO Controls NAD+ Breakdown Inside Mitochondria
Scientists identify SelO as a key regulator of mitochondrial NAD+ metabolism, revealing a conserved protective mechanism against metabolic overload.
Summary
Researchers have uncovered a previously unknown mitochondrial reaction in which the enzyme SELENOO (SelO) breaks down NAD+ into NMN and AMP using manganese as a cofactor. This process depends on a specific selenocysteine residue and is triggered by rising mitochondrial pH — a signal of heightened cellular respiration. The reaction appears to act as a metabolic brake, preventing mitochondria from becoming dangerously overactive. SelO also physically associates with fatty acid oxidation enzymes, giving it a direct role in lipid metabolism. Strikingly, this mechanism is conserved across both bacteria and mammalian cells, suggesting it is ancient and fundamental. The findings open new avenues for understanding NAD+ regulation and its role in aging and metabolic disease.
Detailed Summary
NAD+ is one of the most critical molecules in biology, driving energy metabolism, DNA repair, and cellular signaling. Despite decades of research, how NAD+ is specifically degraded within mitochondria has remained poorly understood — until now.
Using computational screening of potential NAD-binding proteins, the research team identified SELENOO (SelO), a mitochondrial selenoprotein, as an enzyme capable of hydrolyzing NAD+ into nicotinamide mononucleotide (NMN) and AMP. The reaction requires manganese (Mn2+) as a cofactor and critically depends on a selenocysteine-serine-serine (CSS) motif at SelO's C-terminus, particularly the selenocysteine at position 667.
Beyond general metabolic effects, SelO was found to physically interact with fatty acid oxidation (FAO) enzymes, suggesting it directly modulates lipid utilization inside mitochondria. This positions SelO as a molecular regulator at the intersection of NAD+ metabolism and fat burning — both central to longevity and metabolic health.
Importantly, the reaction is activated by elevated mitochondrial matrix pH, which occurs when mitochondrial respiration is running at high intensity. This pH-sensitivity suggests SelO functions as a feedback mechanism — when mitochondria are working too hard, SelO degrades NAD+ to temper the response and protect the organelle from chronic overactivation. The conservation of this pathway in bacteria underscores its evolutionary importance.
For longevity science, these findings are significant. NAD+ decline with age is well-documented and linked to mitochondrial dysfunction. Understanding how NAD+ is consumed — and how that consumption is regulated — could inform strategies for NAD+ supplementation, mitochondrial protection, and metabolic resilience. Caveats include the study's reliance on in silico screening and the fact that in vivo disease-context experiments remain limited based on available abstract information.
Key Findings
- SelO hydrolyzes mitochondrial NAD+ into NMN and AMP using Mn2+ as a cofactor.
- Catalytic activity depends on selenocysteine 667 within SelO's C-terminal CSS motif.
- SelO directly binds fatty acid oxidation enzymes, influencing lipid metabolism.
- Elevated mitochondrial matrix pH activates SelO, acting as a metabolic safety valve.
- This NAD+ degradation mechanism is evolutionarily conserved from bacteria to mammals.
Methodology
The study used in silico screening to identify NAD-binding protein candidates, followed by biochemical characterization of SelO's enzymatic activity. Experiments validated the Mn2+-dependent hydrolysis reaction and mapped critical catalytic residues, with additional work examining SelO's interaction with FAO enzymes in mammalian and bacterial systems.
Study Limitations
Only the abstract was available, limiting assessment of experimental depth, sample sizes, and in vivo validation. It is unclear whether SelO loss-of-function studies in whole organisms were performed. The clinical translatability of findings from bacterial conservation studies to human disease contexts requires further investigation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.